{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68462-659",
      "generic_name": "olopatadine hydrochloride and mometasone furoate",
      "labeler_name": "Glenmark Pharmaceuticals Inc., USA",
      "brand_name": "Ryaltris",
      "active_ingredients": [
        {
          "name": "OLOPATADINE HYDROCHLORIDE",
          "strength": "665 ug/1"
        },
        {
          "name": "MOMETASONE FUROATE MONOHYDRATE",
          "strength": "25 ug/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68462-659-27",
          "description": "12 CARTON in 1 BOX (68462-659-27)  / 1 BOTTLE, SPRAY in 1 CARTON / 240 SPRAY, METERED in 1 BOTTLE, SPRAY",
          "marketing_start_date": "20260113",
          "sample": false
        },
        {
          "package_ndc": "68462-659-84",
          "description": "12 CARTON in 1 BOX (68462-659-84)  / 1 BOTTLE, SPRAY in 1 CARTON / 56 SPRAY, METERED in 1 BOTTLE, SPRAY",
          "marketing_start_date": "20260113",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "rxcui": [
          "2591806",
          "2591812"
        ],
        "spl_set_id": [
          "406be932-f00e-4c66-9dd1-c142090fe822"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462659274"
        ],
        "unii": [
          "2XG66W44KF",
          "MTW0WEG809"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "SPRAY, METERED",
      "spl_id": "ecbea621-93b0-40ce-adce-1d304c4fdb15",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "NASAL"
      ],
      "marketing_start_date": "20260113",
      "product_id": "68462-659_ecbea621-93b0-40ce-adce-1d304c4fdb15",
      "application_number": "NDA211746",
      "brand_name_base": "Ryaltris",
      "pharm_class": [
        "Corticosteroid Hormone Receptor Agonists [MoA]",
        "Corticosteroid Hormone Receptor Agonists [MoA]",
        "Corticosteroid [EPC]",
        "Decreased Histamine Release [PE]",
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]",
        "Histamine-1 Receptor Inhibitor [EPC]",
        "Mast Cell Stabilizer [EPC]"
      ]
    }
  ]
}